Systemic Thyroid Hormone Status During Levothyroxine Therapy In Hypothyroidism: A Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Abstract
CONTEXT: The standard of care for overt hypothyroidism is levothyroxine at doses that normalize serum TSH levels. Whether this approach universally restores thyroid hormone signaling is unknown. OBJECTIVE: To review studies of overt hypothyroidism in which participants were treated with levothyroxine to normalize serum TSH levels and measured other objective markers of thyroid hormone signaling. DESIGN: Databases were searched for studies that reported objective markers of thyroid hormone signaling (serum low-density lipoprotein (LDL), total cholesterol (TC), sex hormone-binding globulin (SHBG), creatine kinase and/or ferritin levels; cognition, energy expenditure, and/or renal function) in levothyroxine monotherapy for overt, primary hypothyroidism among nonpregnant adults with normal serum TSH levels. For studies with LDL, TC and SHBG outcomes, data were pooled using random effects meta-analysis. RESULTS: A total of 99 studies met inclusion criteria, including 65 that reported serum cholesterol data. Meta-analysis showed that levothyroxine-treated hypothyroid participants with normal serum TSH levels had 3.31 ± 1.64 mg/dL higher serum LDL levels (p=0.044) and 9.60 ± 3.55 mg/dL higher serum TC levels (p=0.007) compared to controls. In studies that did not concomitantly assess healthy controls, serum LDL levels were 138.3 ± 4.6 mg/dL (p<0.001) and serum TC levels were 209.6 ± 3.4 mg/dL (p<0.001). Meta-analysis of 2 studies showed no significant difference between SHBG levels of levothyroxine-treated participants and controls. CONCLUSIONS: In studies that utilized levothyroxine monotherapy at doses that normalized the serum TSH for overt, primary hypothyroidism, not all systemic biological markers of thyroid hormone signaling were normalized, including serum LDL and TC levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While LT4 therapy is very effective in normalizing serum TSH levels, it fails to restore euthyroidism in some tissues based on an array of metabolic parameters such as serum cholesterol levels and other biomarkers that remain abnormal in LT4-treated patients, despite a normal serum TSH (14–16).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“a 5% increase in BMI, increased cholesterol”
From Designing a combined liothyronine (LT3), L- thyroxine (LT4) trial in symptomatic hypothyroid subjects on LT4 - the importance of patient selection, choice of LT3 and trial design (2023) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While LT4 therapy is very effective in normalizing serum TSH levels, it fails to restore euthyroidism in some tissues based on an array of metabolic parameters such as serum cholesterol levels and other biomarkers that remain abnormal in LT4treated patients, despite a normal serum TSH [14-16].”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“have higher serum cholesterol and low density lipoprotein levels (19–21)”
From Liothyronine and Desiccated Thyroid Extract in the Treatment of Hypothyroidism (2020) · cites this paper as [19]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Additionally, a meta-analysis of 65 studies revealed that both total cholesterol and LDL cholesterol concentrations remain elevated, even after serum TSH has been normalised.177”
From Hypothyroidism (2024) · cites this paper as [177]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., Stewart, L. A., & the PRISMA-P Group (2015) · BMJ · doi:10.1136/bmj.g7647 · Cited by 13,120 · cited 1×
“A systematic literature search was performed in adherence with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement (18, 19).”
MethodThe Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418
Law, M. R., Wald, N. J., & Thompson, S. G. (1994) · BMJ · doi:10.1136/bmj.308.6925.367 · Cited by 1,210
The epidemiology of thyroid disease
Vanderpump, M. P. J. (2011) · British Medical Bulletin · doi:10.1093/bmb/ldr030 · Cited by 1,179
Jellinger, P. S., Handelsman, Y., Rosenblit, P. D., Bloomgarden, Z. T., Fonseca, V. A., Garber, A. J., Grunberger, G., Guerin, C. K., Bell, D. S. H., Mechanick, J. I., et al. (2017) · Endocrine Practice · doi:10.4158/ep171764.appgl · Cited by 1,094 · cited 2×
“clinically important, this might support the need for amendment of hypothyroidism (2) and lipid (90) guidelines to address screening of serum lipid profiles and”
BackgroundBASIC AND CLINICAL ENDOCRINOLOGY
(1984) · Endocrine Disorders · doi:10.1016/b978-0-407-00346-0.50001-5 · Cited by 612
Saravanan, P., Chau, W. ‐., Roberts, N., Vedhara, K., Greenwood, R., & Dayan, C. M. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01654.x · Cited by 514 · cited 4×
“4536 McAninch et al Thyroid Hormone Status in Levothyroxine Therapy J Clin Endocrinol Metab, December 2018, 103(12):4533–4542”
BackgroundInfluentialBunevičius, R., Kažanavičius, G., Žalinkevičius, R., & Prange, A. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400603 · Cited by 482
Fish, L. H., Schwartz, H. L., Cavanaugh, J., Steffes, M. W., Bantle, J. P., & Oppenheimer, J. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703263161302 · Cited by 353
Zulewski, H., Müller, B., Exer, P., Miserez, A. R., & Staub, J.-J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3810 · Cited by 338
Panicker, V., Saravanan, P., Vaidya, B., Evans, J., Hattersley, A. T., Frayling, T. M., & Dayan, C. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1301 · Cited by 327
Levothyroxine Monotherapy Cannot Guarantee Euthyroidism in All Athyreotic Patients
Gullo, D., Latina, A., Frasca, F., Le Moli, R., Pellegriti, G., & Vigneri, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022552 · Cited by 307
Escobar-Morreale, H. F., Obregón, M. J., Escobar del Rey, F., & Morreale de Escobar, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118353 · Cited by 287
Escobar-Morreale, H. F., del Rey, F. E., Obregón, M. J., & de Escobar, G. M. (1996) · Endocrinology · doi:10.1210/endo.137.6.8641203 · Cited by 261
Zulewski, H. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.3.771 · Cited by 211
Walsh, J. P., Shiels, L., Lim, E. M., Bhagat, C. I., Ward, L. C., Stuckey, B. G. A., Dhaliwal, S. S., Chew, G. T., Bhagat, M. C., & Cussons, A. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030249 · Cited by 210
Clyde, P. W., Harari, A. E., Getka, E. J., & Shakir, K. M. M. (2003) · JAMA · doi:10.1001/jama.290.22.2952 · Cited by 195
Werneck de Castro, J. P., Fonseca, T. L., Ueta, C. B., McAninch, E. A., Abdalla, S., Wittmann, G., Lechan, R. M., Gereben, B., & Bianco, A. C. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77588 · Cited by 184
Self-citationAppelhof, B. C., Fliers, E., Wekking, E. M., Schene, A. H., Huyser, J., Tijssen, J. G. P., Endert, E., van Weert, H. C. P. M., & Wiersinga, W. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2111 · Cited by 183
Escobar-Morreale, H. F., Botella-Carretero, J. I., Gómez-Bueno, M., Galán, J. M., Barrios, V., & Sancho, J. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-6-200503150-00007 · Cited by 182
Is a Normal TSH Synonymous With “Euthyroidism” in Levothyroxine Monotherapy?
Peterson, S. J., McAninch, E. A., & Bianco, A. C. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2660 · Cited by 182
Self-citationTanis, B. C., Westendorp, R. G. J., & Smelt, A. H. M. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.739560.x · Cited by 177
Prevalence and Correction of Hypothyroidism in a Large Cohort of Patients Referred for Dyslipidemia
Diekman, T. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.14.1490 · Cited by 168
Walsh, J. P., Ward, L. C., Burke, V., Bhagat, C. I., Shiels, L., Henley, D., Gillett, M. J., Gilbert, R., Tanner, M., & Stuckey, B. G. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0099 · Cited by 164
Siegmund, W., Spieker, K., Weike, A. I., Giessmann, T., Modess, C., Dabers, T., Kirsch, G., Sänger, E., Engel, G., Hamm, A. O., et al. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02050.x · Cited by 152
Hoang, T. D., Olsen, C. H., Mai, V. Q., Clyde, P. W., & Shakir, M. K. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4107 · Cited by 151
Changes in Lipoprotein(a) Levels in Overt and Subclinical Hypothyroidism Before and During Treatment
Tzotzas, T., Krassas, G. E., Konstantinidis, T., & Bougoulia, M. (2000) · Thyroid · doi:10.1089/thy.2000.10.803 · Cited by 150
Scope and limitations of iodothyronine deiodinases in hypothyroidism
Gereben, B., McAninch, E. A., Ribeiro, M. O., & Bianco, A. C. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.155 · Cited by 146
Self-citationCholesterol as a risk factor for Alzheimer's disease - epidemiological evidence
Kivipelto, M., & Solomon, A. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00685.x · Cited by 132
LITHELL, H., BOBERG, J., HELLSING, K., LJUNGHALL, S., LUNDQVIST, G., VESSBY, B., & WIDE, L. (1981) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1981.tb01758.x · Cited by 128
Celi, F. S., Zemskova, M., Linderman, J. D., Smith, S., Drinkard, B., Sachdev, V., Skarulis, M. C., Kozlosky, M., Csako, G., Costello, R., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1329 · Cited by 125
The history and future of treatment of hypothyroidism
McAninch, E. A., & Bianco, A. C. (2016) · Annals of Internal Medicine · doi:10.7326/m15-1799 · Cited by 118
Self-citation[Epidemiology of thyroid disease].
Shimura, H. (2012) · PubMed · Cited by 103
Wouters, H. J. C. M., van Loon, H. C. M., van der Klauw, M. M., Elderson, M. F., Slagter, S. N., Kobold, A. M., Kema, I. P., Links, T. P., van Vliet-Ostaptchouk, J. V., & Wolffenbuttel, B. H. R. (2017) · Thyroid® · doi:10.1089/thy.2016.0199 · Cited by 97
Jha, A. K., SHARMA, S., Tandon, N., Ramakrishnan, L., Kadhiravan, T., Handa, K. K., Gupta, R., Pandey, R., & CHATURVEDI, P. (2005) · Sleep Medicine · doi:10.1016/j.sleep.2005.05.003 · Cited by 97
Samuels, M. H., Kolobova, I., Smeraglio, A., Peters, D., Purnell, J. Q., & Schuff, K. G. (2016) · Thyroid · doi:10.1089/thy.2015.0345 · Cited by 87
Hypothyroidism as a Cause of Rhabdomyolysis.
Barahona, M. J., Mauri, A., Sucunza, N., Paredes, R., & Wägner, A. M. (2002) · Endocrine Journal · doi:10.1507/endocrj.49.621 · Cited by 87
Increased Oxidizability of Low-Density Lipoproteins in Hypothyroidism
Diekman, T. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.5.1752 · Cited by 83
Arem, R., Escalante, D. A., Arem, N., Morrisett, J. D., & Patsch, W. (1995) · Metabolism · doi:10.1016/0026-0495(95)90075-6 · Cited by 79
Fadeyev, V. V., Morgunova, T. B., Melnichenko, G. A., & Dedov, I. I. (2010) · Hormones · doi:10.14310/horm.2002.1274 · Cited by 77
MULS, E., ROSSENEU, M., BLATON, V., LESAFFRE, E., LAMBERIGTS, G., & MOOR, P. D. (1984) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1984.tb00697.x · Cited by 76
Hypothyroid Myopathy with Unusually High Serum Creatine Kinase Values
Finsterer, J., Stöllberger, C., Grossegger, C., & Kroiss, A. (1999) · Hormone Research in Paediatrics · doi:10.1159/000023462 · Cited by 76
Lipid and lipoprotein pattern in thyroid dysfunction and the effect of therapy
Aviram, M., Luboshitzky, R., & Brook, J. G. (1982) · Clinical Biochemistry · doi:10.1016/s0009-9120(82)90529-x · Cited by 73
Diekman, M. J. M. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.5.1857 · Cited by 72
Triguero, M. L. M., Mijares, A. H., Nguyen, T. T., Muñoz, M. L., Peña, H., Morillas, C., Lorente, D., Lluch, I., & Molina, E. (1998) · Mayo Clinic Proceedings · doi:10.4065/73.9.837 · Cited by 71
Packard, C. J., Shepherd, J., Lindsay, G. M., Gaw, A., & Taskinen, M. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.5.8496312 · Cited by 70
Treated hypothyroidism, cognitive function, and depressed mood in old age: the Rancho Bernardo Study
Kramer, C. K., von Mühlen, D., Kritz-Silverstein, D., & Barrett-Connor, E. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0606 · Cited by 68
Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations
Woeber, K. A. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03343972 · Cited by 67
Valizadeh, M., Seyyed-Majidi, M. R., Hajibeigloo, H., Momtazi, S., Musavinasab, N., & Hayatbakhsh, M. R. (2009) · Endocrine Research · doi:10.1080/07435800903156340 · Cited by 65
Long-term thyroid replacement therapy and levels of lipoprotein(a) and other lipoproteins
Pazos, F. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.2.562 · Cited by 59
A Common DIO2 Polymorphism and Alzheimer Disease Dementia in African and European Americans
McAninch, E. A., Rajan, K. B., Evans, D. A., Jo, S., Chaker, L., Peeters, R. P., Bennett, D. A., Mash, D. C., & Bianco, A. C. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01196 · Cited by 59
Self-citationGORMAN, C. A., JIANG, N.-S., ELLEFSON, R. D., & ELVEBACK, L. R. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-49-1-1 · Cited by 56
THERAPY OF ENDOCRINE DISEASE: T4 + T3 combination therapy: is there a true effect?
Wiersinga, W. M. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0645 · Cited by 52 · cited 2×
“T4/T3 ratios with LT4 monotherapy (98).”
BackgroundBecerra, A., Bellido, D., Luengo, A., PIEDROLA, G., & DELUIS, D. (1999) · Clinical Nutrition · doi:10.1016/s0261-5614(98)80031-9 · Cited by 50
VALDEMARSSON, S., HEDNER, P., & NILSSON‐EHLE, P. (1982) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1982.tb00690.x · Cited by 50
An, J. H., Kim, Y. J., Kim, K. J., Kim, S. H., Kim, N. H., Kim, H. Y., Kim, N. H., Choi, K. M., Baik, S. H., Choi, D. S., et al. (2016) · Endocrine Journal · doi:10.1507/endocrj.ej16-0109 · Cited by 44
Individualised requirements for optimum treatment of hypothyroidism: complex needs, limited options
Hoermann, R., Midgley, J. E. M., Larisch, R., & Dietrich, J. W. (2019) · Drugs in Context · doi:10.7573/dic.212597 · Cited by 41
Treatment of hypothyroidism reduces low-density lipoproteins but not lipoprotein(a)
Klausen, I. C., Nielsen, F. E., Hegedűs, L. D., Gerdes, L. U., Charles, P., & Færgeman, O. (1992) · Metabolism · doi:10.1016/0026-0495(92)90176-b · Cited by 40
New insights into the variable effectiveness of levothyroxine monotherapy for hypothyroidism
McAninch, E. A., & Bianco, A. C. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00325-3 · Cited by 39
Self-citationThyrotrophin Radioimmunoassay: Another Test of Thyroid Function
UTIGER, R. D. (1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-4-627 · Cited by 38
Konukoğlu, D., Ercan, M., & Hâtemi, H. (2002) · PubMed · Cited by 36
Ballantyne, F. C., Epenetos, A. A., Caslake, M., Forsythe, S., & Ballantyne, D. (1979) · Clinical Science · doi:10.1042/cs0570083 · Cited by 35
T4 + T3 combination therapy: any progress?
Wiersinga, W. M. (2019) · Endocrine · doi:10.1007/s12020-019-02052-2 · Cited by 35
TSH may not be a good marker for adequate thyroid hormone replacement therapy
Alevizaki, M., Mantzou, E., Cimponeriu, A. T., Alevizaki, C. C., & Koutras, D. A. (2005) · Wiener klinische Wochenschrift · doi:10.1007/s00508-005-0421-0 · Cited by 34
Kraut, E., & Farahani, P. (2015) · Clinical and Investigative Medicine · doi:10.25011/cim.v38i6.26194 · Cited by 30
Sustained release T3 therapy: animal models and translational applications
Idrees, T., Price, J. D., Piccariello, T., & Bianco, A. C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00544 · Cited by 30
Self-citationDyslipidemia and serum mineral profiles in patients with thyroid disorders
Abdel-Gayoum, A. A. (2014) · Saudi Medical Journal · doi:10.15537/1658-3175.6098 · Cited by 30
Scherer, T., Wolf, P. S., Winhofer, Y., Duan, H., Einwallner, E., Gessl, A., Luger, A., Trattnig, S., Hoffmann, M., Niessner, A., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2112 · Cited by 28
Changes in the distribution and composition of high-density lipoproteins in primary hypothyroidism
Muls, E., Rosseneu, M., Lamberigts, G., & MOOR, P. D. (1985) · Metabolism · doi:10.1016/0026-0495(85)90224-0 · Cited by 28
Effects of thyroxine replacement on lipid profile and endothelial function after thyroidectomy
Erbil, Y., Özbey, N., Giriş, M., Salmaslıoğlu, A., Özarmağan, S., & Tezelman, S. (2007) · British journal of surgery · doi:10.1002/bjs.5915 · Cited by 27
Packard, C. J. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.5.1209 · Cited by 26
Okopień, B., & Krysiak, R. G. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-04-0275 · Cited by 25
Singh, S., & Sarkar, P. D. (2014) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · Cited by 24
Adamarczuk-Janczyszyn, M., Zdrojowy-Wełna, A., Rogala, N., Zatońska, K., & Bednarek-Tupikowska, G. (2016) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/38555 · Cited by 24
Mazaheri, T., Sharifi, F., & Kamali, K. (2014) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-014-0103-4 · Cited by 22
Ito, M., Kitanaka, A., Arishima, T., Kudo, T., Nishihara, E., Kubota, S., Amino, N., Hiraiwa, T., Hanafusa, T., & Miyauchi, A. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0226 · Cited by 21
Razvi, S., Ingoe, L., Ryan, V., Pearce, S. H. S., & Wilkes, S. (2016) · Thyroid Research · doi:10.1186/s13044-016-0034-x · Cited by 21
Paoli, M., de Bellabarba, G. A., Velázquez-Maldonado, E., Mendoza, S., Molina, C. Z., Wang, P., & Glueck, C. J. (1998) · Clinica Chimica Acta · doi:10.1016/s0009-8981(98)00074-6 · Cited by 21
The Effect of Long-Term Thyroxine on Bone Mineral Density and Serum Cholesterol
Fowler, P. B. S., McIvor, J., Sykes, L., & Macrae, K. D. (1996) · Journal of the Royal College of Physicians of London · doi:10.1016/s0035-8819(25)00307-1 · Cited by 20
Systemic Thyroid Hormone Status in Treated Graves’ Disease
Azizi, F., Amouzegar, A., Tohidi, M., Hedayati, M., Cheraghi, L., & Mehrabi, Y. (2019) · Intern J Endocrinol Metab · doi:10.5812/ijem.95385 · Cited by 19
Marchesini, G., Fabbri, A., Bianchi, G. P., Motta, E., Bugianesi, E., Urbini, D., Pascoli, A., & Lodi, A. (1993) · Metabolism · doi:10.1016/0026-0495(93)90123-6 · Cited by 19
Haemostatic and Lipid Abnormalities in Hypothyroidism
Nordøy, A., Vik‐Mo, H., & Berntsen, H. (1976) · Scandinavian Journal of Haematology · doi:10.1111/j.1600-0609.1976.tb01131.x · Cited by 18
Liu, Rahman, Jd, B., Alaupovic, & Kannan (1998) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1998.00274.x · Cited by 16
Erem, C., Suleyman, A. K., Civan, N., Menteşe, A., Nuhoğlu, İ., Uzun, A., Coşkun, H., & Değer, O. (2016) · Endocrine Research · doi:10.3109/07435800.2016.1163722 · Cited by 16
Effects of Vitamin D deficiency treatment on metabolic markers in Hashimoto thyroiditis patients
Anaraki, P. V., Aminorroaya, A., Amini, M., Feizi, A., Iraj, B., & Tabatabaei, A. (2017) · Journal of Research in Medical Sciences · doi:10.4103/1735-1995.199090 · Cited by 16
Gürsoy, A., Cin, M. Ö., Kamel, N., & Güllü, S. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2006.00822.x · Cited by 15
Serum homocysteine levels are decreased in levothyroxine-treated women with autoimmune thyroiditis
Owecki, M., Dorszewska, J., Sawicka‐Gutaj, N., Oczkowska, A., Owecki, M. K., Michalak, M., Fischbach, J., Kozubski, W. P., & Ruchała, M. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-18 · Cited by 14
Çakal, E., Turgut, A., Demirbas, B. T., Özkaya, M., Çakal, B., Serter, R., & Aral, Y. (2008) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0028-1085998 · Cited by 11
Characteristics of Thyroxine 5′-Deiodinase Activity in Human Liver
Hardy, J. J., Thomas, C. L., & Utiger, R. D. (1986) · The American Journal of the Medical Sciences · doi:10.1097/00000441-198610000-00002 · Cited by 11
Assessment of the Adequacy of Thyroid Hormone Replacement Therapy in Hypothyroidism
Brokhin, M., Danzi, S. E., & Klein, I. L. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00631 · Cited by 11
Mazzaferri, E. L. (2006) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)70362-7 · Cited by 10
Biochemical Effects of Levothyroxine Withdrawal in Patients with Differentiated Thyroid Cancer.
Papadakis, G. E., Kalaitzidou, S., Triantafillou, E., Drosou, A., Kakava, K., Dogkas, N., Παππά, Θ., Kaltzidou, V., Tertipi, A., Villiotou, V., et al. (2015) · PubMed · Cited by 10
Biochemical effects of levothyroxine withdrawal in patients with differentiated thyroid cancer
Papadakis, G. E., Kalaitzidou, S., Triantafillou, E., Kakava, K., Drosou, A., Sapera, A., Dogkas, N., Παππά, Θ., Kaltzidou, V., Villiotou, V., et al. (2016) · Endocrine Abstracts · doi:10.1530/endoabs.41.ep1106 · Cited by 9
Kutlutürk, F., Yuce, S., Taşlıyurt, T., Yelken, B., Aytan, P., Öztürk, B., & Yılmaz, A. (2013) · PubMed · Cited by 9
Cognitive function in Hashimoto’s thyroiditis under levothyroxine treatment
Giannouli, V., Toulis, K. A., & Syrmos, N. C. (2014) · HORMONES · doi:10.14310/horm.2002.1507 · Cited by 9
[Psychiatric and cognitive aspects of hypothyroidism].
Sn, B., Bjøro, T., & Heyerdahl, S. (2001) · PubMed · Cited by 8
Guardado-Mendoza, Z. R. (2011) · Revista de Endocrinología y Nutrición · Cited by 8
Guardado‐Mendoza, R. (2011) · Revista de Endocrinología y Nutrición · Cited by 8
Ipotiroidismo e colesterolo: analisi retrospettiva di una casistica trentennale di 1756 pazienti
Sampaolo, G., Campanella, N., Catozzo, V., Ferretti, M., Vichi, G., & Morosini, P. (2014) · Recenti Progressi in Medicina · doi:10.1701/1417.15701 · Cited by 6
[Hypothyroidism, hypocholesteremic agents and rhabdomyolysis].
Gouton, M. (1993) · PubMed · Cited by 6
Giampietro, O., Boni, C. D., Carpi, A., & Buzzigoli, G. (1981) · PubMed · Cited by 5
[Variation in high density lipoprotein cholesterol during treatment of thyroid gland diseases].
Barbier, R., Jc, P., Sassolas, A., & Berthezène, F. (1980) · PubMed · Cited by 4
Mehmetçik, G., Becer, E., & AKBEY, A. (2012) · Turkiye Klinikleri Journal of Medical Sciences · doi:10.5336/medsci.2011-25866 · Cited by 3
Muscle Aches and Fatigue in a Man with Elevated Creatine Kinase
Patel, D. K., Sachmechi, I., Bishnoi, A., & ROSNER, F. (1998) · Hospital Practice · doi:10.1080/21548331.1998.11443733 · Cited by 3
TSH may not be a good marker for adequate thyroid hormone replacement therapy
Staudenherz, A., & Sinzinger, H. F. (2006) · Wiener klinische Wochenschrift · doi:10.1007/s00508-006-0619-9 · Cited by 2
Serum homocysteine levels are decreased in levothyroxine-treated women with autoimmune thyroiditis
Owecki, M., Dorszewska, J., Sawicka‐Gutaj, N., Oczkowska, A., Owecki, M. K., Michalak, M., Fischbach, J., Kozubski, W. P., & Ruchała, M. (2014) · Endocrine Abstracts · doi:10.1530/endoabs.35.p202 · Cited by 2
[Variation in high density lipoprotein cholesterol during treatment of thyroid gland diseases].
Barbier, R., Jc, P., Venard-Sassolas, A., et al. (1980) · PubMed · Cited by 2
[Peripheral thyroid insufficiency. Criteria of equilibrium in treatment with L-thyroxine].
Caron, P. J., Camaré, R., Perret, B., Bennet, A., Fabre, J., Hoff, M., & Jp, L. (1989) · PubMed · Cited by 2
McAninch, E. A., Rajan, K. B., Miller, C. H., & Bianco, A. C. (2018) · Data Archiving and Networked Services (DANS) · doi:10.5061/dryad.7ph3219 · Cited by 2
Self-citation
Research works printed but not linked: 5
- Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, Cooper DS, Kim BW, Peeters RP, Rosenthal MS, Sawka AM. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-1751.
- Medicines Use and Spending in the U.S. A Review of 2016 and Outlook to 2021. QuintilesIMS Institute. Durham, NC: IQVIA Institute for Human Data Science; ed2017.
- Ali A, Sattar A, Myuhammad A, Hameed A, Farooq M. Effect of thyroid hormone replacement therapy on lipid profile in primary hypothyroidism. Pak J Med Health Sci. 2013;7(1):127-129.
- Alaghband-Zadeh J, Wiseman SA, Greenhalgh RM, Carter GD, Powell JT, Fowler PB. L-Thyroxine reduces serum apolipoprotein b and limits progression of arterial disease in women claudicants with elevated serum thyroid-stimulating hormone. Eur J Intern Med. 1992;3:213-218.
- Sampaolo G, Campanella N, Catozzo V, Ferretti M, Vichi G, Morosini P. Relationship between hypothyroidism and cholesterol out of the records of 1756 patients [in Italian]. Recenti Prog Med. 2014;105(2):79-82.
Cited by
Deiodinases and their intricate role in thyroid hormone homeostasis
Luongo, C., Dentice, M., & Salvatore, D. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0218-2 · Cited by 332
Paradigms of dynamic control of thyroid hormone signaling
Bianco, A. C., Dumitrescu, A., Gereben, B., Ribeiro, M. O., Fonseca, T. L., Fernandes, G. W., & Bocco, B. M. L. C. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00275 · Cited by 293
Self-citationJonklaas, J., Bianco, A. C., Cappola, A. R., Celi, F. S., Fliers, E., Heuer, H., McAninch, E. A., Moeller, L. C., Nygaard, B., Sawka, A. M., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0720 · Cited by 172
Self-citationTreatment of Thyroid Dysfunction and Serum Lipids: A Systematic Review and Meta-analysis
Kotwal, A., Cortes, T., Genere, N., Hamidi, O., Jasim, S., Newman, C. B., Prokop, L. J., Murad, M. H., & Alahdab, F. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa672 · Cited by 162
Taylor, P. N., Medici, M. M., Hubalewska-Dydejczyk, A., & Boelaert, K. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01614-3 · Cited by 128
Metadata
- Authors
- McAninch, E. A., Rajan, K. B., Miller, C. H., & Bianco, A. C.
- Affiliations
- Rush University Medical Center (US)
- University of California, Davis (US)
- Northwestern University (US)
- University of Chicago (US)
- Corresponding author
- McAninch, Elizabeth A
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2018-08-15
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC6226605
- OpenAlex
- W2887724139
- Cited by
- 94
- References
- 113
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 11 · 2023: 12 · 2022: 12 · 2021: 12 · 2020: 16 · 2019: 14 · 2018: 2
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Rush University
- National Institutes of Health
- National Institute on Aging (P30AG010129, RF1AG057532, R01AG051635)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK065055)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- levothyroxine, overt hypothyroidism, thyroid hormone signaling, serum LDL cholesterol, total cholesterol, sex hormone-binding globulin, creatine kinase, ferritin, energy expenditure, renal function, cognitive function
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.